Alintegimod
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Alintegimod
- DrugBank Accession Number
- DB18879
- Background
Alintegimod is under investigation in clinical trial NCT06362369 (A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 620.81
Monoisotopic: 620.114321454 - Chemical Formula
- C28H32N2O6S4
- Synonyms
- Alintegimod
- External IDs
- 7HP-349
- 7HP349
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- NX38VST3GU
- CAS number
- 1378535-08-0
- InChI Key
- PSBCCRKKPBQYJK-UHFFFAOYSA-N
- InChI
- InChI=1S/C28H32N2O6S4/c31-27(29(19-23-5-1-15-37-23)20-24-6-2-16-38-24)35-13-11-33-9-10-34-12-14-36-28(32)30(21-25-7-3-17-39-25)22-26-8-4-18-40-26/h1-8,15-18H,9-14,19-22H2
- IUPAC Name
- SMILES
- O=C(OCCOCCOCCOC(=O)N(CC1=CC=CS1)CC1=CC=CS1)N(CC1=CC=CS1)CC1=CC=CS1
References
- General References
- Not Available
- External Links
- ChemSpider
- 123248645
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data1 Completed Treatment Solid Tumors 1 somestatus stop reason just information to hide 1, 2 Recruiting Treatment Advanced Malignant Neoplasm / Advanced Solid Tumors / ALK Genomic Tumor Aberrations / Anaplastic Lymphoma Kinase Genomic Tumor Aberrations / Cancer of the Skin / Colorectal Cancer / Hepatocellular Carcinoma / Liver Cancer / Melanoma / Metastatic Cancer / Microsatellite Instability-high (MSI-H) / Mismatch Repair Deficient (dMMR) / Non-Small Cell Lung Cancer (NSCLC) / Pleural Mesotheliomas / Renal Cancer / Renal Cell Carcinoma (RCC) 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 26, 2024 21:57 / Updated at June 27, 2024 01:29